Treatment Programme

Dosage & preparation

Interactions

Other

Highlighted claims

• Participants are randomised equally to CBASP or BA after baseline assessment. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
• Both interventions last 16 weeks and combine 10 weeks of inpatient or day clinic treatment with 6 weeks of outpatient continuation group therapy. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
• Across the full programme, each participant is scheduled for 20 individual therapy sessions, 26 group therapy sessions, 10 nurse contacts, and 10 exercise therapy sessions. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
• Both trial arms receive the same weekly amount of treatment during the acute phase. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
• Both arms receive standardised guideline-based pharmacotherapy in addition to psychotherapy. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial